Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Neurotech International ( (AU:NTI) ) has issued an announcement.
Neurotech International Ltd has announced its corporate governance framework for the financial year ending June 30, 2025, in alignment with the ASX Corporate Governance Principles and Recommendations. The company has adopted a comprehensive set of governance policies, including a Board Charter, Risk Management Policy, and Anti-Bribery Policy, reflecting its commitment to transparency and integrity. This governance structure is tailored to the company’s current size and nature, with provisions for future expansion as operations grow in scale and complexity, ensuring robust oversight and strategic direction.
More about Neurotech International
Neurotech International Ltd operates in the biotechnology industry, focusing on developing medical solutions and technologies. The company is involved in creating products that cater to neurological conditions, aiming to improve patient outcomes and enhance quality of life.
Average Trading Volume: 811,694
Technical Sentiment Signal: Sell
Current Market Cap: A$13.65M
For an in-depth examination of NTI stock, go to TipRanks’ Overview page.